Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T. Scott(Blood Cancer UK), David Vetrie(Blood Cancer UK)Cancer DiscoverySeptember 14, 201610.1158/2159-8290.cd-16-0263Cited by 132SaveCiteExport RISWatch citationsRelated PapersThe gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases|Nature|1993|1.5kActivating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease|Nature Communications|2024|15